• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cardiac Devices

Eko’s AI Algorithm Detects Pediatric Heart Murmurs With Cardiologist-Level Accuracy

by Fred Pennic 11/12/2018 Leave a Comment

Eko Duo Receives FDA Clearance to Market Combined Digital Stethoscope/ECG Smart Device

Eko’s heart murmur detection AI-driven algorithm outperformed four out of five cardiologists for the detection of heart murmurs in a recent clinical study.During the American Heart Association’s Scientific Sessions 2018, Eko, a cardiac monitoring company that combines non-invasive sensors with machine learning presented a clinical study abstract revealing their murmur detection algorithm outperformed the majority of participating cardiologists. The study entitled, “Artificial Intelligence
Read More

AliveCor Receives “Breakthrough Device” Designation from FDA for Bloodless Hyperkalemia Test

by Fred Pennic 09/11/2018 Leave a Comment

AliveCor Receives “Breakthrough Device” Designation from FDA for Bloodless Hyperkalemia Test

AliveCor, a Mountain View, CA-based digital health  startup developing solutions to transform cardiac care, announced on Monday received “breakthrough device” designation from the U.S. Food and Drug Administration for their bloodless hyperkalemia test. Developed with Mayo Clinic, AliveCor’s KardiaK Platform screens for elevated levels of blood potassium – hyperkalemia, without requiring any blood from the patient.This designation signals that the FDA will consider the technology on an
Read More

Biotricity Releases Mobile Cardiac Telemetry Solution

by Jasmine Pennic 03/05/2018 Leave a Comment

AT&T Taps biotricity To Power Wearable Medical Devices Medical

Biotricity today announced the commercial availability of Bioflux, a real-time, high-precision mobile cardiac telemetry solution for customers. The Bioflux system, which received final FDA approval in December, is a complete solution for cardiac monitoring and diagnosis, consisting of the Bioflux device, proprietary software, and a 24/7 monitoring center that merges seamlessly with physicians’ existing platforms and workflows.The Bioflux system is a complete solution for cardiac monitoring and
Read More

Cardiac Monitoring Startup Eko Devices Raises $5M to Bring Intelligence to Heart Sounds

by HITC Staff 02/28/2018 Leave a Comment

Cardiac Monitoring Startup Eko Raises $5M to Bring Intelligence to Heart Sounds

Eko, a San Francisco, CA-based platform of non-invasive cardiac screening devices, care coordination software, and machine learning algorithms has raised $5 million in Series A funding led by ARTIS Ventures. The round also included participation from Strategic Partners, Dreamlt Ventures, 1812 Ventures, and FOUNDER.org. Eko plans to utilize the funding to accelerate its commercial team and to expand clinical studies on the use of Eko's platform for valvular heart disease screening and heart
Read More

Cardiac Insight Lands $2.5M for Portable, Hand-held ECG Device

by Fred Pennic 05/02/2016 Leave a Comment

Cardiac Insight

 Cardiac Insight, a University of Washington spinoff focused on developing advanced body-worn sensing for diagnostic testing in cardiology has raised $2.5 million in Series C funding. The company will utilize the funding to accelerate the market penetration of it's CardeaScreen™ product as well as finalize the development of the company’s proprietary wearable sensor technology.Cardea’s flagship product is the CardeaScreen, is a 12-lead electrocardiogram (ECG) exam that helps identify young
Read More

FDA Approves Medtronic’s Remote Monitoring Pacemaker App

by Fred Pennic 11/18/2015 1 Comment

The U.S. Food and Drug Administration (FDA) has cleared approval and U.S. commercial availability of Medtronic's MyCareLink Smart(TM) Monitor, an app-based remote monitoring system for patients with implantable pacemakers. The app-based system makes it easy for heart device patients to stay connected to their doctor. How It Works Prescribed by a physician, The MyCareLink Smart Monitor is comprised of a handheld portable device reader and the MyCareLink Smart mobile app, available for free on
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

GE HealthCare to Acquire Caption Health

GE HealthCare to Acquire Caption Health to Expand AI-Guided Ultrasounds

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |